Lumina Therapy Alliance, the nation’s leading collective of highly vetted, in-person mental health practices, is proud to announce that Therapy for Women, a premier Philadelphia-based therapy practice ...
SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics announced encouraging clinical results of NXL-004, the world’s first in situ conversion gene therapy for malignant glioma. The data ...
Spartan Capital Securities, LLC is acting as exclusive placement agent for the offering. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, P.C. is acting as ...
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...
The contemplated joint venture would integrate BMRT’s molecular detection sensors with SafeSpace Global’s existing multimodal AI platform and its emergency response integration partner, 911inform, to ...
“Medical cannabis is entering a new phase of institutional relevance, and CINV is building the kind of platform investors are increasingly looking for,” said Robert Adams, CEO of FOCUS Capital ...
The purchase contract specifically mandates the use of SteraMist iHP technology into passthrough fill boxes—a crucial component in the client's sterile manufacturing and advanced therapeutic ...
In parallel with this reimbursement milestone, ENvue Medical has secured an initial purchase order from Peak Medical, a leading UK-based distributor specializing in stoma care and urology medical ...
Innovative single-device solution integrates proven FemVue and FemChec® technologies to support fallopian tube evaluation and improve workflow efficiency-- ATLANTA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ...
J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports ...
About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...
Hooven, Chairman and CEO of Enable Injections. “Every new market opens the door for more patients to experience therapies in a way that fits their lives. We’re excited to bring our technology to Saudi ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果